Senior insider sale
SVP, Chief Technical Officer at ALLOGENE THERAPEUTICS, INC. — senior position signals high conviction
$18.5K
7.13K shares
What this filing means
BENESKI BENJAMIN MACHINAS plans to sell 7.13K shares of ALLOGENE THERAPEUTICS, INC. valued at approximately $18.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0002057918-26-000001
Officer· SVP, Chief Technical Officer
Since Mar 2026
7.13K
Shares to sell
$18.5K
Approx. market value
7.13K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
2/28/2026
7.13KTotal acquired7.13K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/28/2026 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 7.13K | — |
| Total | 7.13K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.13K
Market value
$18.5K
3/2/2026
Total
Units
7.13K
Value
$18.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/2/2026 | 7.13K | $18.5K | NASDAQ | Planned |
| Total | 7.13K | $18.5K | ||